Updates in Neuroinfectious Disease - Part 3

In part one of this series, Dr. Justin Abbatemarco and Dr. Alberto Priori discussed the use of artificial intelligence in neurology among peers, not just trainees.  Show citation:  Vozzi C, Sibilla M, Sandri D, et al. Education Research: Bridging the Artificial Intelligence Training Gap: Evidence from a National Survey of Italian Neurology Residents. Neurol Educ. 2026;5(1):e200289. Published 2026 Jan 27. doi:10.1212/NE9.0000000000200289  

In the September episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss BrainHealth.com and the AAN's expanding brain health movement.  Stay informed by watching the President's Spotlight video.  

In the fifth episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss dexamethasone and listeria meningitis. 

In the fourth episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the use of dexamethasone in the treatment of pneumococcal meningitis.

In the first installment of this series, Dr. Aaron Zelikovich and Dr. Bhaskar Roy discuss how emerging treatments for myasthenia gravis compare to one another.  Show citation:  McLaren NP, Rosati M, Zhong W, et al. Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments: A Bayesian Network Meta-Analysis. Neurology. 2026;107(3):e218351. doi:10.1212/WNL.0000000000218351  

Dr. Jason Crowell and Ka-Ho Wong discuss national trends in Medicare reimbursement for inpatient neurologic care.  Show citation:  Wong KH, Castillo M, King J, et al. National Trends in Medicare Charges and Reimbursement for Inpatient Neurologic Care, 2013-2023. Neurology. 2026;107(6):e218460. doi:10.1212/WNL.0000000000218460 

In the third episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss HSV encephalitis and dexamethasone. 

In part two of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss pegivirus-associated encephalomyelitis. 

In part one of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss acute necrotizing encephalopathy.

In part one of this series, Drs. Greg Cooper, Trey Bateman, and Gregg Day discussed key takeaways from the 2026 Alzheimer's Association International Conference, focusing on blood-based biomarkers, anti-amyloid therapies, and other important highlights.